Verastem, Inc. (VSTM)
7.76
-0.24
(-3.00%)
USD |
NASDAQ |
Oct 06, 16:00
7.83
+0.07
(+0.90%)
After-Hours: 19:39
Verastem Market Cap : 702.14M for Oct. 6, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 05, 2026 | 723.85M |
| October 02, 2026 | 696.71M |
| October 01, 2026 | 714.80M |
| September 30, 2026 | 728.38M |
| September 29, 2026 | 716.61M |
| September 28, 2026 | 703.04M |
| September 25, 2026 | 700.33M |
| September 24, 2026 | 705.76M |
| September 23, 2026 | 740.14M |
| September 22, 2026 | 757.33M |
| September 21, 2026 | 722.95M |
| September 18, 2026 | 673.18M |
| September 17, 2026 | 683.14M |
| September 16, 2026 | 662.33M |
| September 15, 2026 | 664.13M |
| September 14, 2026 | 679.52M |
| September 11, 2026 | 662.33M |
| September 10, 2026 | 689.47M |
| September 09, 2026 | 718.42M |
| September 08, 2026 | 731.09M |
| September 04, 2026 | 741.95M |
| September 03, 2026 | 722.04M |
| September 02, 2026 | 725.66M |
| September 01, 2026 | 688.56M |
| August 31, 2026 | 653.28M |
| Date | Value |
|---|---|
| August 28, 2026 | 653.28M |
| August 27, 2026 | 667.75M |
| August 26, 2026 | 668.66M |
| August 25, 2026 | 640.61M |
| August 24, 2026 | 620.70M |
| August 21, 2026 | 623.42M |
| August 20, 2026 | 617.08M |
| August 19, 2026 | 660.06M |
| August 18, 2026 | 672.28M |
| August 17, 2026 | 649.66M |
| August 14, 2026 | 595.37M |
| August 13, 2026 | 603.51M |
| August 12, 2026 | 628.85M |
| August 11, 2026 | 637.90M |
| August 10, 2026 | 614.37M |
| August 07, 2026 | 609.85M |
| August 06, 2026 | 534.75M |
| August 05, 2026 | 531.13M |
| August 04, 2026 | 525.70M |
| August 03, 2026 | 499.83M |
| July 31, 2026 | 509.49M |
| July 30, 2026 | 535.84M |
| July 29, 2026 | 527.94M |
| July 28, 2026 | 547.26M |
| July 27, 2026 | 534.09M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.399B |
| Dianthus Therapeutics, Inc. | 4.686B |
| Alnylam Pharmaceuticals, Inc. | 29.96B |
| Savara, Inc. | 954.08M |
| Vericel Corp. | 2.049B |
Market Cap Related Metrics
| PS Ratio | 7.868 |
| Price to Book Value | 14.05 |
| Price | 7.76 |
| Earnings Yield | -31.70% |